首页> 外文期刊>Pharmaceutical statistics. >Estimands in practice: Bridging the gap between study objectives and statistical analysis
【24h】

Estimands in practice: Bridging the gap between study objectives and statistical analysis

机译:实践中的估价:弥合研究目标与统计分析之间的差距

获取原文
获取原文并翻译 | 示例
           

摘要

The International Council for Harmonisation (ICH) guideline E9 Statistical Principles for Clinical Trials (1) was issued in 1998. In October 2014, an addendum to ICH E9 was proposed on statistical principles relating to estimands and sensitivity analyses. The final version of the addendum to ICH E9 (R1) (2) was issued in November 2019. This virtual edition of Pharmaceutical Statistics takes a closer look at some of the progress that has been made since 2018 when implementing the estimand framework within clinical research. The articles discussed in this virtual issue are not new, but a compilation from previous issues. This specific article will act as a refresher for those not familiar with the topic and discuss the ABCs of estimands and their proposed deployment for improving the quality of clinical research. An overview of the more recent Pharmaceutical Statistics articles on estimands will be provided, signifying areas where progress have been made. The articles should be considered as contributions to the ongoing discussions rather than the final word. Finally, a personal perspective on the estimand success story and remaining challenges with proposed solutions will be discussed.
机译:国际协调理事会(ICH)指南E9临床试验统计原则(1)于1998年发布。2014年10月,ICH E9的附录提出了与评估和敏感性分析有关的统计原则。ICH E9(R1)(2)附录的最终版本于2019年11月发布。本虚拟版《药物统计》详细介绍了自2018年在临床研究中实施estimand框架以来取得的一些进展。本期虚拟期刊中讨论的文章并不是新的,而是对前几期文章的汇编。这篇具体的文章将作为不熟悉该主题的人的复习,并讨论评估的基础知识及其为提高临床研究质量而提出的部署。将概述最近关于评估的药物统计文章,指出取得进展的领域。这些文章应该被视为对正在进行的讨论的贡献,而不是最终结论。最后,将讨论estimand成功案例的个人观点,以及建议解决方案的剩余挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号